+86-29-89182091
seplite@sunresin.com

High-Capacity Purification Technology for Iohexol

High-Capacity Purification Technology for Iohexol: Enhancing Quality, Efficiency, and Scalability in API Manufacturing
 
Background: Iohexol as a High-Value Contrast Agent
Iohexol is a widely used non-ionic, water-soluble X-Ray and CT contrast agent. Known for its low osmolality, excellent patient tolerance, and clear imaging performance, it is commonly applied in vascular angiography, spinal imaging, and CT enhancement scans.
 
To ensure product safety, global pharmacopeias set strict limits on related impurities in Iohexol. However, during industrial production, small amounts of acidic impurities and ionizable by-products can remain in the process stream. These impurities not only impact product quality but may also increase the risk of adverse reactions during clinical use.
 
Challenges in Traditional Purification Processes
Conventional purification technologies for Iohexol often face several limitations:
  • High-temperature operations and long purification cycles, creating barriers to industrial scale-up
  • Low adsorption capacity of traditional resins, resulting in limited throughput
  • High operating costs and energy consumption, especially in large-volume production
As the demand for high-purity contrast agents continues to grow, the pharmaceutical industry requires a high-capacity, high-efficiency, and more economical purification solution.
 
Sunresin’s Solution: High-Capacity Purification Method for Iohexol
Sunresin has developed a new purification technology specifically optimized for the unique characteristics of Iohexol. This approach enhances adsorption capacity, improves purification efficiency, and significantly reduces production costs.
 
Key Technical Advantages:
1. High Capacity and Increased Throughput
The process uses ultra-high cross-linked macroporous styrene–divinylbenzene polymer beads as chromatographic packing material.
These materials feature:
  • Large pore size
  • High specific surface area
  • Strong affinity for Iohexol
This results in significantly improved loading capacity and an increase in single-batch production output.
 
2. Excellent Alkaline Stability for Longer Media Lifespan
The styrene–DVB polymer matrix is highly resistant to alkaline conditions.
This allows the packing material to be washed with high-pH solutions, extending its usable lifetime and lowering long-term operating costs.
 
3. One-Step Purification Meeting Pharmacopeia Standards
With this improved adsorption and separation mechanism, Iohexol can be purified to pharmacopeia-compliant quality in a single chromatographic step, achieving:
  • ≥ 90% recovery rate
  • Excellent batch-to-batch consistency
  • Reduced downstream processing workload
 
4. Mild Operating Conditions for Industrial Scale Production
The process uses deionized water as the mobile phase, offering:
  • Safe and mild operating conditions
  • Full compatibility with continuous or large-scale industrial processes
  • Improved environmental sustainability
 
5. Cost-Effective Regeneration and Reusability
The packing material can be regenerated using an ethanol–water solution, which can be recovered and reused.
This further reduces:
  • Chemical consumption
  • Operational costs
  • Environmental impact
 
Driving Pharmaceutical Purification Forward
Sunresin has built comprehensive expertise across the entire purification chain—from specialty adsorbent materials to process development, equipment integration, and industrial-scale implementation.
 
This high-capacity Iohexol purification solution empowers pharmaceutical manufacturers to:
  • Achieve higher product purity and safety
  • Increase production efficiency
  • Extend the service life of separation media
  • Reduce overall manufacturing costs
It also supports the global contrast agent supply chain in meeting the rapidly rising demand for high-quality medical imaging products.
 
Sunresin: Enabling High-Quality and Sustainable API Manufacturing
With deep technical foundations in separation materials and process engineering, Sunresin will continue advancing innovative purification technologies for Iohexol, APIs, intermediates, and other pharmaceutical products—contributing to safer, more efficient, and more sustainable pharmaceutical production worldwide.
  Free Quote

Contact Us

Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com seplite_europe@sunresin.com +86-29-89182091
CONTACT US
Our Product List
Mobile Sorption Module for Gold Extraction
PFAS Removal
Bio-Pharmaceutical & Life Science
Modern biopharmaceutical technologies typically use biological microbial fermentation...
Chemical Industry
Purification of chemical compounds has become a vital part of most industrial processes.
Drinking Water Treatment
Drinking water is essential to life. Every day every human being has to drink and use water for food preparation.
Food & Beverage Industries
Food is closely related to everyone, and the finishing of food comes from people's relentless pursuit...
Hydrometallurgy & Mining
Hydrometallurgy is a technique for extractive metallugry involving the three general area...
Direct Lithium Extraction (DLE)
Sunresin is the major DLE lithium sorbent producer in China which mainly used for extraction lithium from salar brine and geothermal brine etc with high efficiency.
Industry Water Treatment
There are many uses of water in industry and, in most cases, the used water also needs treatment to render...
Plant Extraction
Plant Extraction is a process to gather the trace bioactive compounds from the tissue of a plant.
VOCs Treatment
With the widespread use of chemical products in the industry, more and more organic...
Wastewater Treatment
Wastewater treatment is the process of converting wastewater into an effluent that can be discharged
Latest News
01
2025 07
 Sunresin Bioprocess Materials Achieve DMF Registration, Supporting Global Biopharma Compliance
Sunresin has obtained 10 Drug Master File (DMF) registrations for its chromatography resins used in antibody, vaccine, and gene therapy production. With 9 more products under review, Sunresin provides robust regulatory support for global pharmaceutical customers and accelerates IND/NDA filing efficiency with FDA and EMA compliance.
05
2025 06
 Sunresin Secures Australian Patent for Lithium Adsorbent Innovation
Sunresin New Materials Co., Ltd. is pleased to announce that its invention titled “A Lithium Adsorbent and Its Preparation Method” has been officially granted a patent in Australia.

Leave a Message

Please send any questions you want to know, we will reply to you immediately.
Choose File
Submit
Here to Provide Complete Separation and Purification Solutions
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
Call us on:
+86-29-89182091
+86-29-89182091
seplite@sunresin.com